Toward CRISPR Therapies for Cardiomyopathies-Reference-Cited by-同舟云学术

Toward CRISPR Therapies for Cardiomyopathies

Published:2021-11-09 Issue:19 Volume:144 Page:1525-1527
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Nishiyama Takahiko¹,Bassel-Duby Rhonda¹,Olson Eric N.¹^ORCID

Affiliation:

1. Department of Molecular Biology, Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center, and Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.057203

Reference5 articles.

1. The next generation of CRISPR–Cas technologies and applications

2. Myoediting: Toward Prevention of Muscular Dystrophy by Therapeutic Genome Editing

3. In vivo base editing rescues Hutchinson–Gilford progeria syndrome in mice

4. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates

5. Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient Gene Editing for Heart Disease via ELIP-Based CRISPR Delivery System;Pharmaceutics;2024-02-29

2. CRISPR-Cas9 editing of TLR4 to improve the outcome of cardiac cell therapy;Scientific Reports;2023-03-18

3. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) in Cardiovascular Disease: A Comprehensive Clinical Review on Dilated Cardiomyopathy;Cureus;2023-03-05

4. Selección de lo mejor del año 2022 en cardiopatías familiares y genética cardiovascular;REC: CardioClinics;2023-01

5. Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy;Science Translational Medicine;2022-11-23